AZN
AstraZeneca (AZN) Reels from China Investigation and Investor Suit– Hagens Berman
SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- AstraZeneca (NASDAQ: AZN), the Anglo-Swedish pharmaceutical giant, has seen its stock price...
Read moreDetails
ROSEN, THE FIRST FILING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AZN
NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of...
Read moreDetails
AZN Investors Have Opportunity to Lead AstraZeneca PLC Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES , Jan. 6, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds...
Read moreDetails
AstraZeneca Stock Down Almost 14% in 3 Months: Time to Sell?
AZN's key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Fasenra are likely to drive sales. It has several candidates with...
Read moreDetails
Better Buy: Novo Nordisk vs. AstraZeneca
Novo Nordisk (NVO 0.15%) and AstraZeneca (AZN 0.56%) are among the largest companies in the pharmaceutical industry. Both have generally...
Read moreDetails
ASTRAZENECA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against AstraZeneca PLC – AZN
NEW ORLEANS , Jan. 3, 2025 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General...
Read moreDetails
AstraZeneca PLC Investors: Please contact the Portnoy Law Firm to recover your losses. February 21, 2025 Deadline to file Lead Plaintiff Motion
Investors can contact the law firm at no cost to learn more about recovering their losses Investors can contact the...
Read moreDetails
AZN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK , Jan. 3, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm,...
Read moreDetails
Lowey Dannenberg Notifies AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm
NEW YORK, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers...
Read moreDetails
AstraZeneca (AZN) Reels from China Investigation and Investor Suit– Hagens Berman
SAN FRANCISCO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- AstraZeneca (NASDAQ: AZN), the Anglo-Swedish pharmaceutical giant, has seen its stock price...
Read moreDetails